Low-Dose Rituximab vs. Modified Ponticelli Regimen in the Treatment of Primary Membranous Nephropathy – A Randomized Controlled Trial
Sign Up to like & getrecommendations! Published in 2025 at "Indian Journal of Nephrology"
DOI: 10.25259/ijn_80_2024
Abstract: The modified Ponticelli regimen (mPR) with cyclical steroids and cyclophosphamide is first-line therapy for primary membranous nephropathy (PMN). While low-dose rituximab (RTX) has been effective in inducing remission in PMN, there is a paucity of… read more here.
Keywords: low dose; dose; modified ponticelli; rtx ... See more keywords
The Efficacy of an Initial Prednisone Monotherapy Regimen on PLA2R-associated Idiopathic Membranous Nephropathy.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the College of Physicians and Surgeons--Pakistan : JCPSP"
DOI: 10.29271/jcpsp.2022.03.404
Abstract: The aim of this study was to evaluate the efficacy and safety of prednisone monotherapy for phospholipase A2 receptor (PLA2R)-associated idiopathic membranous nephropathy (IMN). This was a retrospective cohort study involving 32 patients enrolled between… read more here.
Keywords: associated idiopathic; ponticelli regimen; prednisone monotherapy; monotherapy ... See more keywords